Corruption in Drug Research: The Fruits of Patent Protection
The NYT reports on efforts to limit the corruption of medical research by preventing articles ghost authored by drug companies from appearing in medical research. It would have been worth noting that this problem would not exist in the absence of the enormous rents that drug companies earn from patent monopolies. These rents give the drug companies incentives to mislead the public about the effectiveness of their drugs.
-Dean Baker
No comments:
Post a Comment